Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.2K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.2K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.2K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

2.2K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
2.2K
Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

The relationship between maternal experiences of abuse and maternal sensitivity in early mother-infant interactions.

Journal of reproductive and infant psychology·2026
Same author

A qualitative investigation of young people's experiences and views of Early Support Hubs across England.

PloS one·2026
Same author

Can whole-family interventions target violence and parenting in families experiencing domestic violence and abuse? A longitudinal study of the For Baby's Sake programme.

BMC psychology·2026
Same author

Maternal glycaemia and child educational attainment at age 5 in the Born in Bradford cohort.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Barriers to accessing perinatal mental health services in ethnically diverse women in the UK.

BMC psychiatry·2026
Same author

Visual content and thematic analyses of images shared on social media before and after episodes of self-harm in a UK clinical youth sample.

BMJ open·2026

Video Experimental Relacionado

Updated: Apr 12, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K

Tratamiento antidepresivo para la depresión posnatal.

Emma Molyneaux1, Kylee Trevillion1, Louise M Howard1

  • 1Health Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, United Kingdom.

JAMA
|May 20, 2015
PubMed
Resumen

Los inhibidores selectivos de la recaptación de serotonina (ISRS) mejoran la respuesta y la remisión de la depresión posnatal en comparación con el placebo. Sin embargo, los datos sobre los casos graves y las comparaciones con los tratamientos psicológicos siguen siendo insuficientes.

Más Videos Relacionados

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

738
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K

Videos de Experimentos Relacionados

Last Updated: Apr 12, 2026

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
04:29

Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression

Published on: January 7, 2019

29.9K
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
08:15

Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model

Published on: June 6, 2025

738
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
05:19

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

3.7K

Área de la Ciencia:

  • La psiquiatría de la reproducción.
  • Salud mental perinatal en la salud mental perinatal.
  • Intervenciones farmacológicas.

Sus antecedentes:

  • La depresión posparto (DPP) afecta a un número significativo de madres.
  • Las opciones efectivas de tratamiento para la ENP son cruciales para el bienestar de la madre y el bebé.
  • La evidencia actual sobre la eficacia de los antidepresivos en la ENP requiere síntesis.

Objetivo del estudio:

  • Evaluar la asociación entre el uso de antidepresivos y los resultados en mujeres con depresión posparto.
  • Para comparar la efectividad de los antidepresivos frente al placebo y las intervenciones psicológicas para la ENP.

Principales métodos:

  • Revisión sistemática y metanálisis de ensayos controlados aleatorios.
  • Inclusión de estudios que comparan los antidepresivos con el placebo.
  • Evaluación de las tasas de respuesta y remisión como resultados primarios.

Principales resultados:

  • Los inhibidores selectivos de la recaptación de serotonina (ISRS) demostraron una respuesta significativamente mejor y tasas de remisión en comparación con el placebo.
  • Existen datos limitados para la ENP severa o las ideas suicidas.
  • No hay evidencia suficiente para comparar los antidepresivos con las intervenciones psicológicas.

Conclusiones:

  • Los ISRS son efectivos para mejorar la respuesta y la remisión en mujeres con PND.
  • Se necesita más investigación para la ENP severa y la eficacia comparativa con las terapias psicológicas.
  • Los antidepresivos representan una opción viable para el TDP moderado.